Position in CGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,685
+$10,559 QoQ
Shares Held
11,068
+29.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 82 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. CGEN ranks #329 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in CGEN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,685 | 11,068 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $13,126 | 8,580 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $38,821 | 26,410 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $77,710 | 43,658 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $67,952 | 46,543 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $17,123 | 11,192 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $28,910 | 15,974 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $23,550 | 14,019 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $25,314 | 9,812 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $19,042 | 9,618 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,952 | 9,628 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,529 | 8,360 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $64,980 | 92,831 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $18,956 | 26,330 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $16,667 | 25,257 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $282,351 | 152,623 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $657,355 | 204,148 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $567,336 | 131,939 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $477,300 | 79,950 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $489,462 | 59,114 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,158,850 | 134,907 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $517,785 | 42,757 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,500,865 | 92,361 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $626,903 | 41,738 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $211,932 | 29,192 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||